Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/24/2010CN101677993A 化合物 Compound
03/24/2010CN101677992A Composition for inhibiting NADPH oxidase activity
03/24/2010CN101677991A hydroquinone ansamycin formulations
03/24/2010CN101677990A pharmaceutical compositions for inhibiting angiogenesis
03/24/2010CN101677988A Composition for transdermal or transmucosal administration
03/24/2010CN101677987A solubilized formulation of docetaxel without tween 80
03/24/2010CN101677986A Direct dissolution of docetaxel in a solvent in polysorbate 80
03/24/2010CN101677985A hexahydro-cyclooctyl pyrazole cannabinoid modulators
03/24/2010CN101677984A Use of dimiracetam in the treatment of chronic pain
03/24/2010CN101677983A Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists
03/24/2010CN101677982A Combination therapy, composition and methods for the treatment of cardiovascular disorders
03/24/2010CN101677981A Pharmaceutical formulations
03/24/2010CN101677980A Use of oligomers of lactic acid in the treatment of gynaecological disorders
03/24/2010CN101677979A Src family kinase inhibitors
03/24/2010CN101677978A Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
03/24/2010CN101677977A Combination of ER(alpha)+ ligands and histone deacetylase inhibitors for the treatment of cancer
03/24/2010CN101677976A A method of inhibiting HIV replication
03/24/2010CN101677975A n1,n4-bis(buta-1,3-dienyl)butane-1,4-diamine pharmaceutical compositions and methods thereof
03/24/2010CN101677974A Neramexane for the treatment of nystagmus
03/24/2010CN101677973A Composition comprising terpene compounds and methods for inhibiting nerve transmission
03/24/2010CN101677972A Novel combinations of neramexane for the treatment of neurodegenerative disorders
03/24/2010CN101677971A combinations of 5-ht2a inverse agonists and antagonists with antipsychotics
03/24/2010CN101677970A Use of iron chelator for the treatment of myocardial infarction
03/24/2010CN101677967A Modified release solid or semi-solid dosage forms
03/24/2010CN101677964A A pharmaceutical composition of tacrolimus
03/24/2010CN101677961A Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent
03/24/2010CN101677956A Benefit agent containing delivery particle
03/24/2010CN101677955A imatinib mesylate
03/24/2010CN101677954A Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
03/24/2010CN101677953A Terbinafine formulation for iontophoresis
03/24/2010CN101677952A Improved depot formulations
03/24/2010CN101677951A Oral cephalotaxine dosage forms
03/24/2010CN101677949A Stable ophthalmical composition comprising ketotifen and naphazoline and methods of making same
03/24/2010CN101677947A pharmaceutical formulation comprising an insulin derivative
03/24/2010CN101677945A Robust rapid disintegration tablet formulation
03/24/2010CN101677942A Intravesical apaziquone administration following transurethral resection for treating cancer
03/24/2010CN101677941A Aqueous pharmaceutical preparation
03/24/2010CN101677932A Skin-lightening agent containing equol compound as active ingredient
03/24/2010CN101677931A Wrinkling-preventing and -modifying agent
03/24/2010CN101677619A Beverage composition comprising CLA
03/24/2010CN101677606A Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food
03/24/2010CN101677603A Edible composition comprising a slowly digestible or digestion resistant oligosaccharide composition
03/24/2010CN101677572A Method of manufacturing a ruthenium complex
03/24/2010CN101677570A synergistic pesticidal mixtures
03/24/2010CN101677569A 2-cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
03/24/2010CN101677568A Ziprasidone formulations
03/24/2010CN101677567A A synergistic pharmaceutical combination for the treatment of cancer
03/24/2010CN101677564A Modified release formulations of (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine and methods of using the same
03/24/2010CN101677562A Novel compounds
03/24/2010CN101677556A Method for treating cb2 receptor mediated pain
03/24/2010CN101677555A Method for treating cb2 receptor mediated pain
03/24/2010CN101677553A benzimidazoles and pharmaceutical compositions thereof
03/24/2010CN101677551A Methods of use for cyclopamine analogs
03/24/2010CN101677548A urotensin ii receptor antagonists
03/24/2010CN101677547A Indole carboxamides as ikk2 inhibitors
03/24/2010CN101677546A Substituted pyrrolidine compounds with central nervous system activity
03/24/2010CN101677544A Therapeutic agent for glaucoma containing adenosine derivative as active ingredient
03/24/2010CN101677543A Extended release pharmaceutical formulations of s-adenosylmethionine
03/24/2010CN101677542A Compositions and methods of use of phorbol esters
03/24/2010CN101676319A Medical sodium hyaluronate gel for injection
03/24/2010CN101676305A Low molecular weight glucan and preparation method and application thereof
03/24/2010CN101676304A Low-molecular-weight glucan, its preparation method and use
03/24/2010CN101676303A Low-molecular-weight glucan, its preparation method and use
03/24/2010CN101676302A Low molecular weight glucan and preparation method and application thereof
03/24/2010CN101676291A Rapamycin carbonate analog, pharmaceutical composition thereof, and preparation method and uses thereof
03/24/2010CN101676290A Levofloxacin salt, and preparation method thereof and medicament composition
03/24/2010CN101676287A 6-(substituted phenoxy)-tetrazolo[5,1-a] phthalazine derivatives as antuepileptics and their pharmaceutically acceptable salts
03/24/2010CN101676286A Azaindoles useful as inhibitors of JAK and other protein kinases
03/24/2010CN101676285A Azaindoles useful as inhibitors of JAK and other protein kinases
03/24/2010CN101676281A Benzo macrolide compound (3R)- des-O-methyllasiodiplodin, its derivatives and preparation method and use
03/24/2010CN101676270A Novel imidazolidine derivative and use thereof
03/24/2010CN101676267A N-4-(1-cyan cyclopentyl) phenyl-2-(4-picolyl) amidogen-3-pyridinecarboxamide salt
03/24/2010CN101676266A Deuterium-substituted omega-diphenylurea and its derivatives, as well as pharmaceutical composition containing the same
03/24/2010CN101676264A Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
03/24/2010CN101676255A Synthetic method of iodized vegetable fatty acids and their esters
03/24/2010CN101675995A 10-hydroxycamptothecinreagent-delivery lipid ultrasound microbubble agent and its preparation method
03/24/2010CN101675990A Formula comprising pawpaw for treating duodenal ulcer
03/24/2010CN101675981A Paste agent for treating low back pain
03/24/2010CN101675977A Formula comprising black alum for treating hepatopathy
03/24/2010CN101675975A Ultra-high biomass two-way super-molecule diversity multi-source traditional Chinese medicine preparation
03/24/2010CN101675968A Pharmaceutical composition for treating lumbocrural pain and its preparation method
03/24/2010CN101675965A Formula comprising pinellia ternate for treating epigastric pain
03/24/2010CN101675963A An externally-applied Zhengtong liquid
03/24/2010CN101675959A Limaigubang capsule
03/24/2010CN101675951A Formula comprising artemisia capillaries for treating hepatopathy
03/24/2010CN101675949A A monkshood formula for treating diabetes
03/24/2010CN101675943A A formula for a traditional Chinese medicine health capsule and manufacturing technology
03/24/2010CN101675937A A method for preparing the forming of a composite bilirubinate
03/24/2010CN101675936A Immunosuppressant
03/24/2010CN101675935A Use of ginsenoside compound
03/24/2010CN101675934A New use of saponins X of dipsacus asperoides
03/24/2010CN101675933A Use of ginsenoside compound
03/24/2010CN101675932A Composition for preventing and treating amyotrophic lateral sclerosis
03/24/2010CN101675931A New uses of acyl chloride and sulfonyl chloride derivatives in preparing anti-tumor drug
03/24/2010CN101675930A Pharmaceutical composition for treating hyperplasia diseases
03/24/2010CN101675929A Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
03/24/2010CN101675928A Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN101675926A Analgesics and methods of use
03/24/2010CN101675925A Dimethylaminoethyl ginkgolide B mesylate injection and preparation method thereof
1 ... 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 ... 7860